neovascular AMD

4 · 20 / page

Ask MedXY AI

Latest news

Tag

Dopamine-Enhancing Therapies in Age-Related Macular Degeneration: Assessing Risk Reduction for Neovascular Conversion

By MedXY|Jun 25, 2026

This study evaluates the association of dopamine-enhancing drugs, especially levodopa, with lowered 3-year risk of progression from non-neovascular to neovascular AMD, offering promising insight into dopaminergic pathways in AMD management.

Assessing the Impact of Cataract Surgery on Progression from Dry to Neovascular Age-Related Macular Degeneration: Insights from the IRIS® Registry

news

neovascular AMD

Latest news

Dopamine-Enhancing Therapies in Age-Related Macular Degeneration: Assessing Risk Reduction for Neovascular Conversion

Assessing the Impact of Cataract Surgery on Progression from Dry to Neovascular Age-Related Macular Degeneration: Insights from the IRIS® Registry

Predictors of 1-Year Visual Outcome in Central-Involving Submacular Hemorrhage Secondary to Neovascular AMD

Glucagon-Like Peptide-1 Receptor Agonists and Ocular Risks: A Comprehensive Review of Neovascular AMD, Diabetic Retinopathy, and Ischemic Optic Neuropathy in Diabetes